R&D Engineer
Sunrise Group
R&D Engineer
Sunrise Group
FDA-cleared at-home sleep diagnostics via telemedicine
Sunrise Group is building the future of sleep health by combining breakthrough technology with expert care. We started in 2015 with a straightforward idea: sleep diagnosis should happen in the comfort of your own home, not in a hospital. To make that possible, we created a first-of-its-kind chin sensor, carefully validated through clinical research, reviewed by leading sleep experts, and cleared by the FDA.
Since then, Sunrise Group has grown from a single innovation into a complete sleep health company. We now design advanced diagnostic and treatment solutions, and we deliver care directly to patients through Dreem Health, our digital sleep clinic. By serving patients in all 50 states with reimbursed care, we are making sleep treatment more accessible, more personal, and much simpler than it has ever been.
As an R&D Engineer, you’ll help shape the next generation of Sunrise medical devices, from electronics and firmware to mechanics, while growing the team’s expertise in signals and clinical data over time.
Your work will directly improve how patients are diagnosed and treated at home.
Device development
Testing and validation
Signals and clinical link
Quality and regulatory
Support and growth
At Sunrise, we’re tackling real sleep health challenges that affect millions. We keep things clear and simple ✨, value trust and collaboration 🤝, and lead with optimism and compassion 🌞. These are the values that guide everything we do. If you’re looking for the freedom to take ownership of your work, make an impact, and be part of a team where you can bring your ideas to life, Sunrise might just be the right fit.
Dreem Health / Sunrise is an Equal Opportunity Employer. We welcome people of all backgrounds and are committed to building a workplace where everyone feels included and respected. We do not tolerate discrimination or harassment of any kind.
FDA-cleared at-home sleep diagnostics via telemedicine
Sunrise Group develops medical-grade sleep health technology and a digital sleep clinic to diagnose and treat sleep disorders. Its FDA-cleared at-home sleep apnea test uses an 8-gram chin sensor to track mandibular jaw movements and other signals, analyzed by an AI algorithm to detect sleep-disordered breathing and report metrics like respiratory effort and sleep stages. The device is prescribed and paired with a telemedicine care pathway; in 2024 Sunrise acquired Dreem Health to offer end-to-end screening, diagnosis, and treatment for sleep apnea and insomnia through virtual consultations and home-based plans, with access to major US insurers. With over $58 million in funding, Sunrise aims to close the gap in sleep medicine by combining precise at-home diagnostics with telehealth to reach more patients.
Explore more opportunities at Sunrise Group